![Mikhail Sergeevich Nekrasov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Mikhail Sergeevich Nekrasov currently works at NANOLEK LLC, as Chief Executive Officer and Makiz-Pharma ZAO, as Chairman.
Mikhail Sergeevich Nekrasov active positions
Companies | Position | Start |
---|---|---|
Makiz-Pharma ZAO
![]() Makiz-Pharma ZAO Pharmaceuticals: MajorHealth Technology Makiz-Pharma ZAO manufactures pharmaceutical products. Its main products are medicines for cardiovascular problems and gastroenterology. The company was founded in 2001 and is headquartered in Moscow, Russia. | Chairman | - |
Nanolek LLC
![]() Nanolek LLC Pharmaceuticals: MajorHealth Technology Nanolek LLC provides biotechnological services. Its project provides integrated pharmaceutical production facilities with the usage of a new technology platform that allows receiving innovative vaccines and pharmaceuticals based on nanotechnology and nanomaterials. The firm's products include Nanovaccines and other biomedical products, Organogel-based ointments and gels, and Solid dosage forms. The company was Founded on April 28, 2011 and is headquartered in Moscow, Russian Federation. | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Makiz-Pharma ZAO
![]() Makiz-Pharma ZAO Pharmaceuticals: MajorHealth Technology Makiz-Pharma ZAO manufactures pharmaceutical products. Its main products are medicines for cardiovascular problems and gastroenterology. The company was founded in 2001 and is headquartered in Moscow, Russia. | Health Technology |
Nanolek LLC
![]() Nanolek LLC Pharmaceuticals: MajorHealth Technology Nanolek LLC provides biotechnological services. Its project provides integrated pharmaceutical production facilities with the usage of a new technology platform that allows receiving innovative vaccines and pharmaceuticals based on nanotechnology and nanomaterials. The firm's products include Nanovaccines and other biomedical products, Organogel-based ointments and gels, and Solid dosage forms. The company was Founded on April 28, 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |
- Stock Market
- Insiders
- Mikhail Sergeevich Nekrasov